Nuzenio

Tradingview Insm

Tradingview Insm entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 11 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Insmed Incorporated Stock 12‑Month Price Target Raised to $197.14, Implies 99% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:22 GMTINSM: BRINSUPRI's historic growth drove raised guidance and improved financial outlook for 2026 - TradingViewTradingView · Thu, 06 Aug 2026 14:32:29 GMTInsmed Q2 revenue beats estimates - TradingViewTradingView · Thu, 06 Aug 2026 11:21:01 GMTINSM: Raised 2026 guidance follows robust Q2 results and strong clinical progress for key assets - TradingViewTradingView · Thu, 06 Aug 2026 11:15:43 GMTInsmed Reports Q2 2026 Revenue of $425.5M; Raises BRINSUPRI Guidance to $1.25B–$1.40B - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTINSM: Q2 2026 revenues rose 296% to $425.5M, driven by BRINSUPRI and ARIKAYCE growth - TradingViewTradingView · Thu, 06 Aug 2026 11:01:40 GMTINSMED Inc Q2 2026: Revenue $425.5M, EPS $(0.06) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:01:01 GMTINSM: Q2 2026 revenue surged 296% to $425.5M, led by BRINSUPRI launch and ARIKAYCE growth - TradingViewTradingView · Thu, 06 Aug 2026 11:00:56 GMT

Timeline

Thu, 06 Aug 2026 23:20:22 GMTInsmed Incorporated Stock 12‑Month Price Target Raised to $197.14, Implies 99% Upside - TradingView
Thu, 06 Aug 2026 14:32:29 GMTINSM: BRINSUPRI's historic growth drove raised guidance and improved financial outlook for 2026 - TradingView
Thu, 06 Aug 2026 11:21:01 GMTInsmed Q2 revenue beats estimates - TradingView
Thu, 06 Aug 2026 11:15:43 GMTINSM: Raised 2026 guidance follows robust Q2 results and strong clinical progress for key assets - TradingView
Thu, 06 Aug 2026 11:03:01 GMTInsmed Reports Q2 2026 Revenue of $425.5M; Raises BRINSUPRI Guidance to $1.25B–$1.40B - TradingView
Thu, 06 Aug 2026 11:01:40 GMTINSM: Q2 2026 revenues rose 296% to $425.5M, driven by BRINSUPRI and ARIKAYCE growth - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Insm.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.